MENU
SYRE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Spyre Therapeutics (SYRE) Ownership - Who owns Spyre Therapeutics?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
221 Crescent Street
Phone
+1 617 651-5940
Employees
30
Web
https://www.spyre.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.4B
P/E Ratio
1.72
Total Cash
414.23M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
3.76
Dividend Yield
N/A
Total Cash/Share
7.06
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SYRE
Capitalization
1.4B
P/E Ratio
1.72
Risk (Beta)
3.76
Dividend Yield
N/A
Total Cash
414M
Total Cash/Share
7.06
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
172M
P/B Ratio
8.16
Cash Flow
N/A
Earnings
-37.9
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
7.32
Current Revenue Per Employee
49142.86
Dividends Per Share - Security
N/A
EBITDA
-195.07M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-68.40
Shares Held By Institutions
2.04B
Shares Outstanding - Current
58.7M
Total Liabilities
93.7M
Total Volume MTD
N/A
Value
-1
Gain YTD
10.874
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
221 Crescent Street
Phone
+1 617 651-5940
Employees
30
Web
https://www.spyre.com